Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 103

1.

Recognizing that Evidence is Made, not Born.

Lim R, Lee DK, Sabourin P, Ferguson J, Metcalf M, Smith M, Corriol-Rohou S, Eichler HG, Lumpkin M, Hirsch G, Chen IM, O'Rourke B, Schiel A, Crabb N, Aronson N, Pezalla E, Boutin M, Binder L, Wilhelm L.

Clin Pharmacol Ther. 2019 Apr;105(4):844-856. doi: 10.1002/cpt.1317. Epub 2019 Jan 4.

PMID:
30472743
2.

Expanding global access to essential medicines: investment priorities for sustainably strengthening medical product regulatory systems.

Roth L, Bempong D, Babigumira JB, Banoo S, Cooke E, Jeffreys D, Kasonde L, Leufkens HGM, Lim JCW, Lumpkin M, Mahlangu G, Peeling RW, Rees H, Ndomondo-Sigonda M, Stergachis A, Ward M, Nwokike J.

Global Health. 2018 Nov 1;14(1):102. doi: 10.1186/s12992-018-0421-2. Review.

3.

Optimized Medical Product Regulation in Mexico: A Win-Win for Public and Economic Health.

Arriola Peñalosa MA, Cavazos Cepeda R, Alanis Garza M, Lumpkin MM.

Ther Innov Regul Sci. 2017 Nov;51(6):744-750. doi: 10.1177/2168479017701503. Epub 2017 May 5.

PMID:
30227102
4.

The cost of entry: An analysis of pharmaceutical registration fees in low-, middle-, and high-income countries.

Morgan SG, Yau B, Lumpkin MM.

PLoS One. 2017 Aug 15;12(8):e0182742. doi: 10.1371/journal.pone.0182742. eCollection 2017.

5.

Corrigendum: Adaptive biomedical innovation: Evolving our global system to sustainably and safely bring new medicines to patients in need.

Hirsch G, Trusheim M, Cobbs E, Bala M, Garner S, Hartman D, Isaacs K, Lumpkin M, Lim R, Oye K, Pezalla E, Saltonstall P, Selker H.

Clin Pharmacol Ther. 2017 Apr;101(4):542. doi: 10.1002/cpt.643. No abstract available.

PMID:
28318021
6.

Speeding Access to Vaccines and Medicines in Low- and Middle-Income Countries: A Case for Change and a Framework for Optimized Product Market Authorization.

Ahonkhai V, Martins SF, Portet A, Lumpkin M, Hartman D.

PLoS One. 2016 Nov 16;11(11):e0166515. doi: 10.1371/journal.pone.0166515. eCollection 2016.

7.

"Threshold-crossing": A Useful Way to Establish the Counterfactual in Clinical Trials?

Eichler HG, Bloechl-Daum B, Bauer P, Bretz F, Brown J, Hampson LV, Honig P, Krams M, Leufkens H, Lim R, Lumpkin MM, Murphy MJ, Pignatti F, Posch M, Schneeweiss S, Trusheim M, Koenig F.

Clin Pharmacol Ther. 2016 Dec;100(6):699-712. doi: 10.1002/cpt.515. Epub 2016 Oct 19.

8.

Adaptive Biomedical Innovation: Evolving Our Global System to Sustainably and Safely Bring New Medicines to Patients in Need.

Hirsch G, Trusheim M, Cobbs E, Bala M, Garner S, Hartman D, Isaacs K, Lumpkin M, Lim R, Oye K, Pezalla E, Saltonstall P, Selker H.

Clin Pharmacol Ther. 2016 Dec;100(6):685-698. doi: 10.1002/cpt.509. Epub 2016 Oct 22. Erratum in: Clin Pharmacol Ther. 2017 Apr;101(4):542.

9.

Predicting lung dosimetry of inhaled particleborne benzo[a]pyrene using physiologically based pharmacokinetic modeling.

Campbell J, Franzen A, Van Landingham C, Lumpkin M, Crowell S, Meredith C, Loccisano A, Gentry R, Clewell H.

Inhal Toxicol. 2016 Sep;28(11):520-35. doi: 10.1080/08958378.2016.1214768.

10.

Medicines Adaptive Pathways to Patients (MAPPs): A Story of International Collaboration Leading to Implementation.

Schulthess D, Baird LG, Trusheim M, Unger TF, Lumpkin M, Hoos A, Garner S, Gavin P, Goldman M, Seigneuret N, Chlebus M, Van Baelen K, Bergstrom R, Hirsch G.

Ther Innov Regul Sci. 2016 May;50(3):347-354. doi: 10.1177/2168479015618697.

PMID:
30227070
11.

Accelerating access to new medicines: Current status of facilitated regulatory pathways used by emerging regulatory authorities.

Liberti L, Breckenridge A, Hoekman J, Leufkens H, Lumpkin M, McAuslane N, Stolk P, Zhi K, Rägo L.

J Public Health Policy. 2016 Aug;37(3):315-333. doi: 10.1057/jphp.2016.8. Epub 2016 Mar 10.

PMID:
26961261
12.

From adaptive licensing to adaptive pathways: delivering a flexible life-span approach to bring new drugs to patients.

Eichler HG, Baird LG, Barker R, Bloechl-Daum B, Børlum-Kristensen F, Brown J, Chua R, Del Signore S, Dugan U, Ferguson J, Garner S, Goettsch W, Haigh J, Honig P, Hoos A, Huckle P, Kondo T, Le Cam Y, Leufkens H, Lim R, Longson C, Lumpkin M, Maraganore J, O'Rourke B, Oye K, Pezalla E, Pignatti F, Raine J, Rasi G, Salmonson T, Samaha D, Schneeweiss S, Siviero PD, Skinner M, Teagarden JR, Tominaga T, Trusheim MR, Tunis S, Unger TF, Vamvakas S, Hirsch G.

Clin Pharmacol Ther. 2015 Mar;97(3):234-46. doi: 10.1002/cpt.59. Epub 2015 Feb 4.

PMID:
25669457
13.

Pharmacokinetic data distinguish abusive versus dietary supplement uses of 1,3-dimethylamylamine.

Rodricks JV, Lumpkin MH, Schilling BK.

Ann Emerg Med. 2013 Jun;61(6):718-9. doi: 10.1016/j.annemergmed.2012.11.022. No abstract available.

PMID:
23684331
14.

DMAA as a dietary ingredient.

Rodricks JV, Lumpkin MH.

JAMA Intern Med. 2013 Apr 8;173(7):594-5. doi: 10.1001/jamainternmed.2013.2533. No abstract available.

PMID:
23568631
15.

Advancing the science of medicines regulation: the role of the 21st-century medicines regulator.

Lumpkin MM, Eichler HG, Breckenridge A, Hamburg MA, Lönngren T, Woods K.

Clin Pharmacol Ther. 2012 Oct;92(4):486-93. doi: 10.1038/clpt.2012.146. Epub 2012 Sep 5. Review.

PMID:
22948890
16.

Adaptive licensing: taking the next step in the evolution of drug approval.

Eichler HG, Oye K, Baird LG, Abadie E, Brown J, Drum CL, Ferguson J, Garner S, Honig P, Hukkelhoven M, Lim JC, Lim R, Lumpkin MM, Neil G, O'Rourke B, Pezalla E, Shoda D, Seyfert-Margolis V, Sigal EV, Sobotka J, Tan D, Unger TF, Hirsch G.

Clin Pharmacol Ther. 2012 Mar;91(3):426-37. doi: 10.1038/clpt.2011.345. Epub 2012 Feb 15. Review.

PMID:
22336591
17.

Stress biomarkers in medical students participating in a mind body medicine skills program.

Maclaughlin BW, Wang D, Noone AM, Liu N, Harazduk N, Lumpkin M, Haramati A, Saunders P, Dutton M, Amri H.

Evid Based Complement Alternat Med. 2011;2011:950461. doi: 10.1093/ecam/neq039. Epub 2011 Jun 8.

18.

Significant pediatric morbidity and mortality from intracranial ballistic injuries caused by nonpowder gunshot wounds. A case series.

O'Neill PJ, Lumpkin MF, Clapp B, Kopelman TR, Matthews MR, Cox JC, Caruso DM, Feiz-Erfan I.

Pediatr Neurosurg. 2009;45(3):205-9. doi: 10.1159/000222671. Epub 2009 Jun 3.

PMID:
19494565
19.

Acrolein environmental levels and potential for human exposure.

Faroon O, Roney N, Taylor J, Ashizawa A, Lumpkin MH, Plewak DJ.

Toxicol Ind Health. 2008 Sep;24(8):543-64. doi: 10.1177/0748233708098124.

PMID:
19039083
20.

Acrolein health effects.

Faroon O, Roney N, Taylor J, Ashizawa A, Lumpkin MH, Plewak DJ.

Toxicol Ind Health. 2008 Aug;24(7):447-90. doi: 10.1177/0748233708094188. Review.

PMID:
19028774
21.

Promoting self-awareness and reflection through an experiential mind-body skills course for first year medical students.

Saunders PA, Tractenberg RE, Chaterji R, Amri H, Harazduk N, Gordon JS, Lumpkin M, Haramati A.

Med Teach. 2007 Oct;29(8):778-84. Epub 2007 Sep 27.

22.

A large-sample survey of first- and second-year medical student attitudes toward complementary and alternative medicine in the curriculum and in practice.

Chaterji R, Tractenberg RE, Amri H, Lumpkin M, Amorosi SB, Haramati A.

Altern Ther Health Med. 2007 Jan-Feb;13(1):30-5.

23.

The FDA goes global.

Lumpkin MM, Bachorik L.

FDA Consum. 2006 Jan-Feb;40(1):68-9. No abstract available.

24.

CAM in medical education: has the time come?

Oberbaum M, Shuval J, Haramati A, Singer SR, Halevi J, Lumpkin MD, Carmi R.

Isr Med Assoc J. 2005 Sep;7(9):607-10. No abstract available.

25.

Global regulatory issues.

Lumpkin MM.

Clin Adv Hematol Oncol. 2004 Dec;2(12):776-8. No abstract available.

PMID:
16166952
26.

Overcrowded motor vehicle trauma from the smuggling of illegal immigrants in the desert of the Southwest.

Lumpkin MF, Judkins D, Porter JM, Latifi R, Williams MD.

Am Surg. 2004 Dec;70(12):1078-82.

PMID:
15663048
27.

Surgeon reimbursement for trauma care.

Lumpkin MF, Judkins DG, Porter JM, Williams MD.

Am J Surg. 2004 Dec;188(6):767-71.

PMID:
15619497
28.

Complementary and alternative medicine: opportunities for education and research.

Haramati A, Lumpkin MD.

Exp Biol Med (Maywood). 2004 Sep;229(8):695-7. Review. No abstract available.

PMID:
15337823
29.

PBPK modeling of the metabolic interactions of carbon tetrachloride and tetrachloroethylene in B6C3F1 mice.

Fisher J, Lumpkin M, Boyd J, Mahle D, Bruckner JV, El-Masri HA.

Environ Toxicol Pharmacol. 2004 Mar;16(1-2):93-105. doi: 10.1016/j.etap.2003.10.006.

PMID:
21782696
30.

Plasma binding of trichloroacetic acid in mice, rats, and humans under cancer bioassay and environmental exposure conditions.

Lumpkin MH, Bruckner JV, Campbell JL, Dallas CE, White CA, Fisher JW.

Drug Metab Dispos. 2003 Oct;31(10):1203-7.

PMID:
12975328
31.

Peptide T bolus normalizes the growth hormone secretion pattern in two children with AIDS.

Barbey-Morel C, McDonnell K, Pert CB, Adams M, Farrand D, Ruff MR, Lumpkin MD.

Peptides. 2002 Dec;23(12):2279-81.

PMID:
12535709
32.

Studying protein-carbohydrate interactions by amide hydrogen/deuterium exchange mass spectrometry.

King D, Lumpkin M, Bergmann C, Orlando R.

Rapid Commun Mass Spectrom. 2002;16(16):1569-74.

PMID:
12203249
33.

The pharmacokinetics of perchlorate and its effect on the hypothalamus-pituitary-thyroid axis in the male rat.

Yu KO, Narayanan L, Mattie DR, Godfrey RJ, Todd PN, Sterner TR, Mahle DA, Lumpkin MH, Fisher JW.

Toxicol Appl Pharmacol. 2002 Jul 15;182(2):148-59.

PMID:
12140178
34.

Integrating complementary and alternative medicine into conventional medical education: role of basic science.

Haramati A, Lumpkin MD.

Arch Intern Med. 2001 Jul 9;161(13):1679; author reply 1680-1. No abstract available.

PMID:
11434803
35.

Toward a redefinition of psychiatric emergency.

Claassen CA, Hughes CW, Gilfillan S, McIntire D, Roose A, Lumpkin M, Rush AJ.

Health Serv Res. 2000 Aug;35(3):735-54.

36.
37.

Cardiovascular fitness, body composition, and lipoprotein lipid metabolism in older men.

Goldberg AP, Busby-Whitehead MJ, Katzel LI, Krauss RM, Lumpkin M, Hagberg JM.

J Gerontol A Biol Sci Med Sci. 2000 Jun;55(6):M342-9.

PMID:
10843355
38.

Peptide T blocks GP120/CCR5 chemokine receptor-mediated chemotaxis.

Redwine LS, Pert CB, Rone JD, Nixon R, Vance M, Sandler B, Lumpkin MD, Dieter DJ, Ruff MR.

Clin Immunol. 1999 Nov;93(2):124-31.

PMID:
10527688
39.

The safety of newly approved medicines: do recent market removals mean there is a problem?

Friedman MA, Woodcock J, Lumpkin MM, Shuren JE, Hass AE, Thompson LJ.

JAMA. 1999 May 12;281(18):1728-34.

PMID:
10328074
40.

FDA public health advisory: low molecular-weight heparin and spinal/epidural anesthesia or spinal puncture.

Lumpkin MM.

Int J Trauma Nurs. 1998 Apr-Jun;4(2):56-7. No abstract available.

PMID:
9855967
41.

HIV gp120 inhibits the somatotropic axis: a possible GH-releasing hormone receptor mechanism for the pathogenesis of AIDS wasting.

Mulroney SE, McDonnell KJ, Pert CB, Ruff MR, Resch Z, Samson WK, Lumpkin MD.

Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1927-32.

42.

FDA public health advisory.

Lumpkin MM.

Anesthesiology. 1998 Feb;88(2):27A-28A. No abstract available.

PMID:
9477044
43.

Approval of new drugs in the United States. Comparison with the United Kingdom, Germany, and Japan.

Kessler DA, Hass AE, Feiden KL, Lumpkin M, Temple R.

JAMA. 1996 Dec 11;276(22):1826-31.

PMID:
8946904
44.
45.

Safety alert: hazards of precipitation associated with parenteral nutrition.

Lumpkin MM.

Am J Hosp Pharm. 1994 Jun 1;51(11):1427-8. No abstract available.

PMID:
7942876
46.

Early increase in pulsatile growth hormone release after unilateral nephrectomy in adult rats.

Haramati A, Lumpkin MD, Mulroney SE.

Am J Physiol. 1994 Apr;266(4 Pt 2):F628-32.

PMID:
8184896
47.

Tandospirone stimulates prolactin secretion in the rat by an action at serotonin-1A receptors.

Mulroney SE, Skudlarek C, Shemer A, Lumpkin MD, Kellar KJ.

J Pharmacol Exp Ther. 1994 Feb;268(2):862-7.

PMID:
8113999
48.

Clinical trials from a regulator's perspective.

Lumpkin MM.

Infection. 1994;22 Suppl 1:S61-4. No abstract available.

PMID:
8050801
49.

Stimulation of serotonin1A receptors increases release of prolactin in the rat.

Kellar KJ, Hulihan-Giblin BA, Mulroney SE, Lumpkin MD, Flores CM.

Neuropharmacology. 1992 Jul;31(7):643-7.

PMID:
1357574

Supplemental Content

Loading ...
Support Center